Cartesian Therapeutics
RNAC
#6926
Rank
ยฃ0.36 B
Marketcap
ยฃ14.20
Share price
-1.47%
Change (1 day)
-17.70%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -ยฃ0.26

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.25. In 2021 the company made an earnings per share (EPS) of -ยฃ0.19 an increase over its 2020 EPS that were of -ยฃ0.54.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.26
2021-ยฃ0.19-65.22%
2020-ยฃ0.54-43.44%
2019-ยฃ0.96-58.08%
2018-ยฃ2.29-9.35%
2017-ยฃ2.53-29.16%
2016-ยฃ3.57